Abstract CT020: MERIT: introducing individualized cancer vaccines for the treatment of TNBC - a phase I trialSandra Heesch, Uğur Şahin, Mustafa Diken et al.|Cancer Research|2016Cited by 5
Abstract CT201: The Mutanome Engineered RNA Immuno-Therapy (MERIT) projectSandra Heesch, Uğur Şahin, Cedrik M. Britten et al.|Cancer Research|2015Cited by 1